InvestorsHub Logo
Followers 71
Posts 9391
Boards Moderated 0
Alias Born 07/17/2013

Re: georgejjl post# 79238

Saturday, 11/22/2014 7:16:21 PM

Saturday, November 22, 2014 7:16:21 PM

Post# of 402726
LOL. I don't recall that being the issue at hand nor do I recall anyone making that statement. And saying the COO misspoke to bolster your argument is just absurd.

In response to:

Obviously, the new COO was misquoted.

I am sure that what he meant to say was:

"..."I believe the safety profile of Kevetrin has been very well evaluated in the current trial and is reassuring when Kevetrin is used in combination with other therapy and potentially as a single agent...."

If you don't believe me, then email him yourself.

Kevetrin has not shown sufficient activity as a single agent to warrant FDA approval as a single agent.





As always, in my opinion only. Do your own due diligence!

Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent IPIX News